JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

ViewAll
Cover and Contents

Cover and Contents

Full Issue

Full Issue

Articles

Original Article - Oncology

Effect of vitamin D on prognosis in patients with gastric cancer

https://doi.org/10.51271/JCHOR-0026

: 569 : 173

Citation : Sezgin Y, Aydın İ, Biçer A, Can A. Effect of vitamin D on prognosis in patients with gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):1-5.

Original Article - Hematology

Do mean platelet volume and platelet count vary on a daily or gender basis?

https://doi.org/10.51271/JCHOR-0027

: 808 : 195

Citation : Candar Ö, Ekinci Ö, Doğan A, Ebinç S. Do mean platelet volume and platelet count vary on a daily or gender basis? J Curr Hematol Oncol Res. 2024;2(1):6-9.

Original Article - Hematology

Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center

https://doi.org/10.51271/JCHOR-0028

: 447 : 419

Citation : Doğan E, Küçükoğlu E, Keklik M. Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center. J Curr Hematol Oncol Res. 2024;2(1):10-14.

https://doi.org/10.51271/JCHOR-0029

: 745 : 161

Citation : Güner G, Ürün M. Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with HER-2 negative metastatic gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):15-19.

https://doi.org/10.51271/JCHOR-0030

: 936 : 242

Citation : Çelik S, Kaynar L. Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis. J Curr Hematol Oncol Res. 2023; 1(1): 15-17.

https://doi.org/10.51271/JCHOR-0031

: 508 : 144

Citation : Yılmaz S, Bağcı M, Baştürk A. Contributions of ELN2022 update and new genetic analysis tests in the risk assesment and treatment of acute myeloid leukaemia. J Curr Hematol Oncol Res. 2024;2(1):22-23.
_Footer